Canaccord Names Guardant Health (GH) Top Life Science Pick, Cites Strong Growth and Low Downside
Guardant Health Inc. (NASDAQ:GH) is one of the hottest large-cap stocks of 2025.
Guardant Health Inc. (GH)
Market is closed
Sector: Services-Medical Laboratories
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 219,454,000 | $286,281,230 | 8.49% | ||
| 2. | Deep Track Capital David Kroin | 4,154,086 | $259,547,293 | -3% | 7.24% |
| 3. | Driehaus Capital Richard Driehaus | 2,152,315 | $134,476,641 | -14% | 0.96% |
| 4. | Cadian Capital Eric Bannasch | 2,141,191 | $133,781,614 | -33% | 7.95% |
| 5. | Two Sigma Advisors John Overdeck And David Siegel | 2,112,800 | $132,007,744 | -12% | 0.26% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $17.82 | 2,187 | $38,962.72 | 12,722 | 2024-03-18 | Filing | |
| $32.78 | 750 | $24,584.25 | 5,193 | 2023-06-09 | Filing | |
| $32.68 | 2,231 | $72,913.77 | 4,443 | 2023-06-09 | Filing | |
| $26.15 | 8,600 | $224,927.84 | 2,049,238 | 2023-03-15 | Filing | |
| $26.33 | 84,452 | $2,223,908.30 | 2,040,638 | 2023-03-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $101.46 | 116 | $11,769.36 | 7,993 | 2025-12-17 | Filing | |
| $104.02 | 6,620 | $688,628.29 | 2,047,143 | 2025-12-15 | Filing | |
| $103.80 | 83,945 | $8,713,591.73 | 2,053,763 | 2025-12-15 | Filing | |
| $104.04 | 5,451 | $567,131.85 | 7,012 | 2025-12-15 | Filing | |
| $106.00 | 4,240 | $449,440.00 | 168,223 | 2025-12-08 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,860 | $292,120 | 0.27% | |
| 2. | 808 | $82,529 | 0% | |
| 3. | 5 | $511 | 0% | |
| 4. | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
News See All
10 Hottest Large-Cap Stocks of 2025
On December 22, Scott Wren, chief global equity strategist at Wells Fargo Investment Institute, joined CNBC's 'Squawk on the Street' to express optimism regarding accelerating earnings alongside moderating...
Multiple Analysts Lift Guardant Health, Inc. (GH) Targets on Screening and Data Growth
TheFly reported on December 17 that Mizuho analyst Anthony Petrone maintained an Outperform rating on GH and raised the price target to $120 from $100, reflecting growing confidence in the company’...
7 Most Promising Gene Editing Stocks According to Analysts
Gene editing has rapidly evolved into a transformative class of technologies that allow scientists to precisely insert, delete, or modify DNA within living cells.
Guardant Health (GH) Jumps to New Record High on Earnings Blowout, Bullish Outlook
In an updated report, Guardant Health Inc.
Guardant Health, Inc. (NASDAQ:GH) Q3 2025 Earnings Call Transcript
Operator: Good afternoon. Thank you for attending the Guardant Health Q3 2025 Earnings Call. My name is Cameron, and I'll be your moderator for today.
12 Best Performing Healthcare Stocks to Buy Right Now
Spending on healthcare in the US is predicted to hit $5.3 trillion this year, making it one of the largest in the world.
Guardant Health, Inc. (NASDAQ:GH) Q2 2025 Earnings Call Transcript
Operator: Good afternoon, and thank you for attending the Guardant Health Q2 2025 Earnings Conference Call. My name is Jason, and I'll be the moderator today.
Guardant Health Enrolls First Patient in NCI Vanguard Study for Multi-Cancer Detection Test
Guardant Health Inc. (NASDAQ:GH) is one of the best mid cap pharma stocks to buy.
Hedge Fund Resource Center Billionaire Hedge Funds
